Reversible activation of c-Myc in thymocytes enhances positive selection and induces proliferation and apoptosis in vitro
- 6 April 2000
- journal article
- Published by Springer Nature in Oncogene
- Vol. 19 (15) , 1891-1900
- https://doi.org/10.1038/sj.onc.1203508
Abstract
In order to study the effect of c-Myc activation in T lymphocytes in vivo, we generated transgenic mice that express a 4-hydroxytamoxifen (4-OHT)-dependent switchable c-myc oncoprotein under the control of the proximal lck promoter. Activation of c-MycER causes no obvious alteration in T cell ontogeny. However, using MHC class I restricted H-Y-TCR transgenic mice, we found that c-Myc activation in vivo enhances the efficiency of positive selection. Moreover, splenic T cells derived from lck-c-mycER transgenic mice in which c-Myc had been activated exhibited increased proliferation in vitro in response to activation with anti-CD3/CD28 antibody. Activation of c-MycER also promotes apoptosis in thymocytes in vitro.Keywords
This publication has 39 references indexed in Scilit:
- Reversible Activation of c-Myc in SkinMolecular Cell, 1999
- Turnover of naive- and memory-phenotype T cells.The Journal of Experimental Medicine, 1994
- Myc—Max—Mad: a transcription factor network controlling cell cycle progression, differentiation and deathCurrent Opinion in Genetics & Development, 1994
- Mad: A heterodimeric partner for Max that antagonizes Myc transcriptional activityCell, 1993
- Induction of apoptosis in fibroblasts by c-myc proteinCell, 1992
- Developmental regulation of lck gene expression in T lymphocytes.The Journal of Experimental Medicine, 1991
- Sequence-Specific DNA Binding by the c-Myc ProteinScience, 1990
- Developmental Biology of T Cells in T Cell-Receptor Transgenic MiceAnnual Review of Immunology, 1990
- The Regulation and Expression of c-myc in Normal and Malignant CellsAnnual Review of Immunology, 1986
- The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic miceNature, 1985